Try Fund Library Premium

Free with a 30 day trial!

Gain access to

  • Unlimited Watchlists
  • Advanced Search Filtering
  • Fund Comparisons
  • Portfolio Scenarios
  • Customizable PDF Reports
  • Portfolio Rebalancer new

KalVista Pharmaceuticals Inc. (KALV : NSD)

Sector: Healthcare

Close
(04-29-2026)
$26.67
Change
$7.43 (38.62%)
Volume 71,359,866
Open $26.70
Day Range $26.66 - $26.76
52 Week Low $9.83
52 Week High $26.76
Annual Yield -
Annual Dividend -
Last Dividend -
Industry Sector Healthcare
Quoted Market Value $1,348,069,634
Shares Outstanding 50,546,293
Book Value per Share $78.44
Earnings per Share -$3.95
Period
Loading......
Loading......

Legend

KalVista Pharmaceuticals Inc.

Compare Options


Pricing History (Last 30 Days)

Pricing History
Date Close Change
April 29, 2026 26.67
$7.43 (38.62%)
April 28, 2026 19.24
$0.08 (0.42%)
April 27, 2026 19.16
-$0.47 (-2.39%)
April 24, 2026 19.63
$0.55 (2.88%)
April 23, 2026 19.08
-$0.48 (-2.45%)
April 22, 2026 19.56
$0.13 (0.67%)
April 21, 2026 19.43
-$1.44 (-6.90%)
April 20, 2026 20.87
$0.39 (1.90%)
April 17, 2026 20.48
$0.92 (4.70%)
April 16, 2026 19.56
-$1.30 (-6.23%)
April 15, 2026 20.86
$0.57 (2.81%)
April 14, 2026 20.29
$0.70 (3.57%)
April 13, 2026 19.59
$0.20 (1.03%)
April 10, 2026 19.39
-$0.56 (-2.81%)
April 09, 2026 19.95
$0.68 (3.53%)
April 08, 2026 19.27
-$0.85 (-4.22%)
April 07, 2026 20.12
-$0.07 (-0.35%)
April 06, 2026 20.19
$0.29 (1.46%)
April 03, 2026 19.90
$0.00 (0.00%)
April 02, 2026 19.90
$0.13 (0.66%)
April 01, 2026 19.77
-$0.36 (-1.79%)
March 31, 2026 20.13
$1.77 (9.64%)
March 30, 2026 18.36
-$0.97 (-5.02%)
March 27, 2026 19.33
$0.38 (2.01%)
March 26, 2026 18.95
$1.81 (10.56%)
March 25, 2026 17.14
$0.68 (4.13%)
March 24, 2026 16.46
-$0.14 (-0.84%)
March 23, 2026 16.60
-$0.40 (-2.35%)
March 20, 2026 17.00
$0.57 (3.47%)
March 19, 2026 16.43
$0.94 (6.07%)

Funds holding this stock

Try Fund Library Premium

Free with a 30 day trial!

Gain access to

  • Unlimited Watchlists
  • Advanced Search Filtering
  • Fund Comparisons
  • Portfolio Scenarios
  • Customizable PDF Reports
  • Portfolio Rebalancer new